BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11311223)

  • 1. Serum crosslaps in comparison to serum osteocalcin and urinary bone resorption markers.
    Peichl P; Griesmacherb A; Marteau R; Hejc S; Kumpan W; Müller MM; Bröll H
    Clin Biochem; 2001 Mar; 34(2):131-9. PubMed ID: 11311223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum osteocalcin and urinary crosslaps are suitable markers of bone turnover in response to short-term hormone replacement therapy.
    Peichl P; Griesmacher A; Müller MM; Marteau R; Kumpan W; Bröll H
    Gynecol Endocrinol; 2000 Oct; 14(5):374-81. PubMed ID: 11109977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of osteocalcin and CrossLaps as markers of bone turnover in children with chronic renal failure].
    Polak-Jonkisz D; Zwolińska D; Bednorz R; Owczarek H; Nahaczewska W
    Pol Merkur Lekarski; 2002 Apr; 12(70):257-60. PubMed ID: 12089882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between female sex hormones and biochemical markers of bone turnover in peri- and postmenopausal women.
    Peichl P; Griesmacher A; Pointinger P; Marteau R; Hartl W; Gruber W; Bröll H
    Calcif Tissue Int; 1998 May; 62(5):388-94. PubMed ID: 9541515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
    Garnero P; Gineyts E; Riou JP; Delmas PD
    J Clin Endocrinol Metab; 1994 Sep; 79(3):780-5. PubMed ID: 8077361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides.
    Christgau S; Rosenquist C; Alexandersen P; Bjarnason NH; Ravn P; Fledelius C; Herling C; Qvist P; Christiansen C
    Clin Chem; 1998 Nov; 44(11):2290-300. PubMed ID: 9799756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and application of a serum C-telopeptide and osteocalcin assay to measure bone turnover in an ovariectomized rat model.
    Srivastava AK; Bhattacharyya S; Castillo G; Wergedal J; Mohan S; Baylink DJ
    Calcif Tissue Int; 2000 Jun; 66(6):435-42. PubMed ID: 10821880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline.
    Okabe R; Inaba M; Nakatsuka K; Miki T; Naka H; Moriguchi A; Nishizawa Y
    J Bone Miner Metab; 2004; 22(2):127-31. PubMed ID: 14999523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of bone disease in multiple myeloma: a comparison between the resorption markers urinary deoxypyridinoline/creatinine (DPD) and serum ICTP, and an evaluation of the DPD/osteocalcin and ICTP/osteocalcin ratios.
    Carlson K; Larsson A; Simonsson B; Turesson I; Westin J; Ljunghall S
    Eur J Haematol; 1999 May; 62(5):300-6. PubMed ID: 10359057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific changes of urinary excretion of cross-linked N-telopeptides of type I collagen in pre- and postmenopausal women: correlation with other markers of bone turnover.
    Gorai I; Taguchi Y; Chaki O; Nakayama M; Minaguchi H
    Calcif Tissue Int; 1997 Apr; 60(4):317-22. PubMed ID: 9075625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations of new markers of bone formation and resorption in kidney transplant recipients.
    Małyszko J; Wołczyński S; Małyszko JS; Konstantynowicz J; Kaczmarski M; Myśliwiec M
    Transplant Proc; 2003 Jun; 35(4):1351-4. PubMed ID: 12826157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism.
    Minisola S; Pacitti MT; Rosso R; Pellegrino C; Ombricolo E; Pisani D; Romagnoli E; Damiani C; Aliberti G; Scarda A; Mazzuoli SF
    J Endocrinol Invest; 1997 Oct; 20(9):559-65. PubMed ID: 9413811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical usefulness of urinary CrossLaps as a sensitive marker of bone metabolism.
    Nakayama H; Yano T; Sagara Y; Ando K; Kasai Y; Taketani Y
    Endocr J; 1997 Aug; 44(4):479-84. PubMed ID: 9447279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of the Elecsys beta-CrossLaps serum assay, a new assay for degradation products of type I collagen C-tlopeptides.
    Okabe R; Nakatsuka K; Inaba M; Miki T; Naka H; Masaki H; Moriguchi A; Nishizawa Y
    Clin Chem; 2001 Aug; 47(8):1410-4. PubMed ID: 11468230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
    Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K
    J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional evaluation of bone metabolism in men.
    Szulc P; Garnero P; Munoz F; Marchand F; Delmas PD
    J Bone Miner Res; 2001 Sep; 16(9):1642-50. PubMed ID: 11547833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between long-term use of a typical antipsychotic medication by Chinese schizophrenia patients and the bone turnover markers serum osteocalcin and β-CrossLaps.
    Zhang B; Deng L; Wu H; Lu X; Peng L; Wu R; Guo W; Chen J; Li L; Zhao J
    Schizophr Res; 2016 Oct; 176(2-3):259-263. PubMed ID: 27377977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood serum osteocalcin and beta-crosslaps concentrations in patients after renal transplantation].
    Zbróg Z; Tomaszek M; Szuflet A; Pierzchalska-Mudyna T; Rybińska A; Skrzypek A; Matych J
    Przegl Lek; 2007; 64(6):431-4. PubMed ID: 18159853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices.
    Woitge HW; Pecherstorfer M; Li Y; Keck AV; Horn E; Ziegler R; Seibel MJ
    J Bone Miner Res; 1999 May; 14(5):792-801. PubMed ID: 10320528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.
    Garnero P; Shih WJ; Gineyts E; Karpf DB; Delmas PD
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1693-700. PubMed ID: 7989477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.